[SYRS] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
12-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -13.13%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 15,093 1,982 2,050 1,101 317 317 0 -
PBT -84,038 -75,438 -62,279 -54,010 -47,743 -29,818 -13,431 35.70%
Tax 1,792 2,550 2,017 -1,527 0 0 0 -
NP -85,830 -75,438 -62,279 -54,010 -47,743 -29,818 -13,431 36.18%
Tax Rate - - - - - - - -
Total Cost 100,923 77,420 64,329 55,111 48,060 30,135 13,431 39.90%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -568.67 -3,806.16 -3,038.00 -4,905.54 -15,060.88 -9,406.31 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -18.64 -18.76 -19.07 -21.26 -37.60 -120.45 -54.25 -16.29%
EPS Diluted -18.64 -18.76 -19.07 -21.26 -37.60 -120.45 -54.25 -16.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.